8-K: Neuraxis Declares Series B Preferred Stock Dividend

Neuraxis, Inc. announced its Board of Directors authorized a stock dividend on its Series B Preferred Stock for the third quarter of 2026, payable in common stock.

Summary

• Neuraxis, Inc. announced that its Board of Directors has authorized and declared a stock dividend for its Series B Preferred Stock for the third quarter of 2026.
• The dividend will be paid in shares of the Company's common stock.
• The number of common shares issued will be based on accrued dividends from July 1, 2026, to the record date, divided by $2.38 per share.
• Approximately 81,339 shares of common stock are expected to be issued.
• Holders entitled to fractional shares will receive cash equal to $2.38 multiplied by the fraction of a share they would have received.
• The dividend is payable on October 30, 2026, to shareholders of record as of October 26, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive development, as it involves a dividend payment, but it's paid in common stock which dilutes existing shareholders.

Positives

• The company is distributing a dividend to its preferred shareholders, indicating a return of value.
• The dividend payment mechanism is clearly defined.

Negatives

• The dividend is paid in common stock, which will result in dilution for existing common shareholders.
• The value of the dividend is fixed at $2.38 per share, which may not reflect current market conditions or the company's performance.

Risks

• Potential for increased share count due to stock dividend, which could dilute earnings per share.
• The fixed dividend conversion price of $2.38 may not be favorable if the common stock price is significantly higher or lower.

Future Outlook

The filing indicates a dividend payment for the third quarter of 2026, payable in common stock. No other forward-looking statements regarding future financial performance or strategic initiatives are present in this specific filing.

Management Comments

• The Board of Directors authorized and the Company declared a stock dividend on the Company's Series B Preferred Stock for the third quarter of 2026.
• The Third Quarter Dividend will be paid in the form of shares of the Company's common stock.

Industry Context

StockSavvy.ai notes that paying dividends in stock is a common practice, especially for companies seeking to conserve cash. However, it inherently leads to dilution for existing common shareholders, a factor investors will closely monitor.

Stakeholder Impact

• Common Shareholders: Potential dilution of ownership percentage and earnings per share due to the issuance of new common stock.
• Series B Preferred Shareholders: Will receive a dividend in the form of common stock, increasing their equity stake in the company, but the value is fixed at $2.38 per share.
• Creditors: No direct immediate impact, but increased share count could indirectly affect financial ratios if earnings do not keep pace.

Next Steps

• Payment of the stock dividend on October 30, 2026.
• Issuance of approximately 81,339 shares of common stock to Series B Preferred Stock holders.

Key Dates

Keywords

stock dividend, preferred stock, common stock, dividend payment, shareholder value, dilution, Neuraxis